Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $59.67 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $59.67 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $59.67 | 3 | Novartis Pharmaceuticals Corporation ($59.67) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Dermatology | ||||||
| 06/12/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Dermatology | ||||||
| 04/17/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 480 | 650 | $61,286 | $15,322 |
| 2021 | 27 | 2,440 | 4,054 | $460,692 | $209,764 |
| 2020 | 24 | 2,407 | 3,951 | $462,931 | $200,143 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 177 | $18,585 | $5,748 | 30.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 75 | 75 | $9,675 | $2,905 | 30.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 84 | 87 | $8,787 | $2,494 | 28.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 21 | 29 | $2,059 | $1,039 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 42 | $2,688 | $884.73 | 32.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 59 | 208 | $15,184 | $854.11 | 5.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $2,527 | $788.08 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 13 | 13 | $1,781 | $608.77 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 689 | 1,051 | $108,264 | $66,769 | 61.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 307 | 364 | $46,956 | $26,776 | 57.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 361 | 534 | $53,934 | $21,131 | 39.2% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 49 | 53 | $20,246 | $11,890 | 58.7% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 25 | 26 | $19,136 | $9,903 | 51.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 106 | 106 | $14,098 | $8,498 | 60.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 167 | 208 | $13,114 | $8,334 | 63.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 79 | 88 | $12,056 | $7,299 | 60.5% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 35 | 42 | $9,240 | $5,742 | 62.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 240 | 1,150 | $83,950 | $5,464 | 6.5% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 88 | 110 | $7,810 | $4,614 | 59.1% |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | Office | 2021 | 33 | 38 | $6,878 | $3,780 | 55.0% |
| 11642 | Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | Office | 2021 | 27 | 33 | $11,286 | $3,647 | 32.3% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 29 | 32 | $9,952 | $3,223 | 32.4% |
| 12031 | Repair of wound (2.5 centimeters or less) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 12 | 13 | $3,835 | $2,793 | 72.8% |
| 17281 | Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 18 | 22 | $4,950 | $2,748 | 55.5% |
| 17271 | Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals | Office | 2021 | 20 | 21 | $4,326 | $2,149 | 49.7% |
About Dr. Phyllis Murphy, MD
Dr. Phyllis Murphy, MD is a Procedural Dermatology healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508954066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phyllis Murphy, MD has received a total of $59.67 in payments from pharmaceutical and medical device companies, with $59.67 received in 2023. These payments were reported across 3 transactions from 1 company. The most common payment nature is "Food and Beverage" ($59.67).
As a Medicare-enrolled provider, Murphy has provided services to 5,327 Medicare beneficiaries, totaling 8,655 services with total Medicare billing of $425,228. Data is available for 3 years (2020–2022), covering 59 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Location Clearwater, FL
- Active Since 10/10/2006
- Last Updated 08/12/2019
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508954066
Products in Payments
- COSENTYX (Drug) $59.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.